Notes
Midwest Comparative Effectiveness Public Advisory Council
Reference
Institute for Clinical and Economic Review. ICER Releases Draft Evidence Report on Crisaborole and Dupilumab for Atopic Dermatitis. Internet Document : 24 Mar 2017. Available from: URL: https://icer-review.org/announcements/ad-draft-report/
Rights and permissions
About this article
Cite this article
ICER draft report on crisaborole and dupilumab for dermatitis. PharmacoEcon Outcomes News 775, 6 (2017). https://doi.org/10.1007/s40274-017-3870-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3870-6